PharVision Advisers’s Altria Group MO Stock Holding History

PharVision Advisers’s Portfolio MO Stock Details MO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,843	Closed	-$225K	–	744
2025 Q2	$225K	Buy	+3,843	New	+$226K	0.32%	166

Other funds holding MO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PharVision Advisers's MO Position: Q3 2025 in Review

PharVision Advisers sold out of Altria Group (MO) in Q3 2025, closing a stake of 3,843 shares — an estimated $225K sold.

PharVision Advisers first reported a position in MO in Q2 2025 and held it in 1 quarter. The position peaked at $225K in Q2 2025. 2,350 funds tracked by Wall St. Rank hold MO as of Q3 2025.

PharVision Advisers reported no remaining Altria Group position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 3,843 Altria Group shares in Q3 2025, an estimated $225K.
PharVision Advisers first reported a position in Altria Group in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Altria Group position peaked at $225K in Q2 2025.
2,350 funds tracked by Wall St. Rank held Altria Group as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.